Prevalence and types of persistent dyslipidemia in patients treated with statins

AIM: To determine the prevalence and types of persistent dyslipidemia in patients treated with different statins to reduce cardiovascular disease (CVD) risk, as well as to determine the proportion of high risk patients who did not reach the lipid target values and assess cardiologists' further...

Descripción completa

Detalles Bibliográficos
Autores principales: Reiner, Željko, Tedeschi-Reiner, Eugenia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Croatian Medical Schools 2013
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3760657/
https://www.ncbi.nlm.nih.gov/pubmed/23986274
http://dx.doi.org/10.3325/cmj.2013.54.339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3760657/
https://www.ncbi.nlm.nih.gov/pubmed/23986274
http://dx.doi.org/10.3325/cmj.2013.54.339

Ejemplares similares